Macron Picks Lecornu as France’s New Prime Minister

Equity markets saw gains as investors awaited crucial inflation data, with commentary also focusing on revised jobs figures. Separately, a perspective emerged regarding New York's strong future positioning.

Analysis

Equity markets are demonstrating a risk-on posture, with stocks advancing ahead of a pivotal inflation data release scheduled for September 8, 2025. This moderately positive market sentiment is occurring as investors also digest revised jobs data, with commentary from a former Bureau of Labor Statistics (BLS) Commissioner highlighting a keen focus on the macroeconomic landscape. Beyond these primary drivers, specific sector and regional outlooks are also in focus. A positive long-term viewpoint on New York's economic positioning was articulated by an individual named Kimball. Separately, the healthcare and biotech sectors face a significant near-term catalyst, as the FDA is expected to release a report on the root cause of autism within the next month, an event which could introduce material volatility for related equities.

Key Decisions for Investors

• Given that equity markets have advanced ahead of the September 8 inflation report, investors should consider the risk of a market reversal if the data disappoints expectations.
• Portfolio managers should review positions in the healthcare and biotech sectors to manage potential volatility surrounding the FDA's upcoming report on autism, as this represents a significant binary catalyst.
• The interplay between the revised jobs data and the incoming inflation print will be critical for gauging future monetary policy, warranting close attention from a macro strategy perspective.